Mice lacking the β3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome

被引:1
作者
DeLorey, TM
Handforth, A
Anagnostaras, SG
Homanics, GE
Minassian, BA
Asatourian, A
Fanselow, MS
Delgado-Escueta, A
Ellison, GD
Olsen, RW [1 ]
机构
[1] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA
[3] W Los Angeles Vet Affairs Med Ctr, Div Neurol, Los Angeles, CA 90073 USA
[4] Univ Pittsburgh, Dept Anesthesiol Crit Care Med, Pittsburgh, PA 15261 USA
关键词
epilepsy; seizure; Angelman syndrome; GABA(A) receptor; mouse model; GABRB3; learning and memory; hyperactivity; motor coordination; sleep;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Angelman syndrome (AS) is a severe neurodevelopmental disorder resulting from a deletion/mutation in maternal chromosome 15q11-13. The genes in 15q11-13 contributing to the full array of the clinical phenotype are not fully identified. This study examines whether a loss or reduction in the GABA(A) receptor beta(3) subunit (GABRB3) gene, contained within the AS deletion region, may contribute to the overall severity of AS. Disrupting the gabrb3 gene in mice produces electroencephalographic abnormalities, seizures, and behavior that parallel those seen in AS. The seizures that are observed in these mice showed a pharmacological response profile to antiepileptic medications similar to that observed in AS. Additionally, these mice exhibited learning and memory deficits, poor motor skills on a repetitive task, hyperactivity, and a disturbed rest-activity cycle, features all common to AS. The loss of the single gene, gabrb3, in these mice is sufficient to cause phenotypic traits that have marked similarities to the clinical features of AS, indicating that impaired expression of the GABRB3 gene in humans probably contributes to the overall phenotype of Angelman syndrome. At least one other gene, the EG-associated protein ubiquitin-protein ligase (UBE3A) gene, has been implicated in AS, so the relative contribution of the GABRB3 gene alone or in combination with other genes remains to be established.
引用
收藏
页码:8505 / 8514
页数:10
相关论文
共 41 条
  • [1] ANGELMAN SYNDROME DUE TO PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME-15 - A MILDER PHENOTYPE
    BOTTANI, A
    ROBINSON, WP
    DELOZIERBLANCHET, CD
    ENGEL, E
    MORRIS, MA
    SCHMITT, B
    THUNHOHENSTEIN, L
    SCHINZEL, A
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1994, 51 (01): : 35 - 40
  • [2] THE EEG IN EARLY DIAGNOSIS OF THE ANGELMAN (HAPPY PUPPET) SYNDROME
    BOYD, SG
    HARDEN, A
    PATTON, MA
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1988, 147 (05) : 508 - 513
  • [3] INHERITED MICRODELETIONS IN THE ANGELMAN AND PRADER-WILLI SYNDROMES DEFINE AN IMPRINTING CENTER ON HUMAN-CHROMOSOME-15
    BUITING, K
    SAITOH, S
    GROSS, S
    DITTRICH, B
    SCHWARTZ, S
    NICHOLLS, RD
    HORSTHEMKE, B
    [J]. NATURE GENETICS, 1995, 9 (04) : 395 - 400
  • [4] Chen C, 1996, BEHAV NEUROSCI, V110, P1177
  • [5] CHRISTIAN SI, 1995, AM J HUM GENET, V57, P40
  • [6] CYCLIC VARIATIONS IN EEG DURING SLEEP AND THEIR RELATION TO EYE MOVEMENTS, BODY MOTILITY, AND DREAMING
    DEMENT, W
    KLEITMAN, N
    [J]. ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1957, 9 (04): : 673 - 690
  • [7] CHRONIC ADMINISTRATION OF TYPICAL, BUT NOT ATYPICAL NEUROLEPTICS INDUCE PERSISTING ALTERATIONS IN REST-ACTIVITY CYCLES IN RATS
    ELLISON, G
    SEE, RE
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (04) : 807 - 811
  • [8] NALOXONE AND SHOCK-ELICITED FREEZING IN THE RAT
    FANSELOW, MS
    BOLLES, RC
    [J]. JOURNAL OF COMPARATIVE AND PHYSIOLOGICAL PSYCHOLOGY, 1979, 93 (04): : 736 - 744
  • [9] Godsil B. P., 1997, Society for Neuroscience Abstracts, V23, P1612
  • [10] Cortical myoclonus in angelman syndrome
    Guerrini, R
    DeLorey, TM
    Bonanni, P
    Moncla, A
    Dravet, C
    Suisse, G
    Livet, MO
    Bureau, M
    Malzac, P
    Genton, P
    Thomas, P
    Sartucci, F
    Simi, P
    Serratosa, JM
    [J]. ANNALS OF NEUROLOGY, 1996, 40 (01) : 39 - 48